Acadian Asset Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Acadian Asset Management’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-529,851	Closed	-$2.02M	–	1867
2016 Q3	$2.02M	Sell	529,851 -151,533	-22%	-$690K	0.01%	540
2016 Q2	$3.54M	Sell	681,384 -24,500	-3%	-$140K	0.02%	438
2016 Q1	$3.41M	Sell	705,884 -24,600	-3%	-$108K	0.02%	459
2015 Q4	$3.42M	Sell	730,484 -9,200	-1%	-$39.8K	0.02%	467
2015 Q3	$2.73M	Sell	739,684 -212,577	-22%	-$1.48M	0.01%	495
2015 Q2	$8.13M	Sell	952,261 -91,300	-9%	-$910K	0.04%	322
2015 Q1	$9.45M	Buy	1,043,561 +4,900	+0.5%	+$61.5K	0.04%	294
2014 Q4	$15M	Buy	+1,038,661	New	+$15.1M	0.07%	237

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Acadian Asset Management's CPHR Position: Q4 2016 in Review

Acadian Asset Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 529,851 shares — an estimated $2.02M sold.

Acadian Asset Management first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $15M in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Acadian Asset Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Acadian Asset Management sold 529,851 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $2.02M.
Acadian Asset Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
Acadian Asset Management's Cipher Pharmaceuticals Inc. position peaked at $15M in Q4 2014.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Acadian Asset Management's 13F filing for Q4 2016, filed 19 Jan 2017.